Prevalence and Impact of Anxiety and Depression on Type 2 Diabetes in Tunisian Patients over Sixty Years Old

Table 5

Clinical and therapeutic characteristics of diabetes according to depression and anxiety average scores.

Clinical and therapeutic characteristics	AAS (SD)	𝑃	DAS (SD)	𝑃
Balanced diabetes
Yes	6.5 (3.1)	0.017	5 (3.1)	0.14
No	9.1 (4.2)		6.7 (4.7)
Comorbidity type
Dyslipidemia
Yes	9.1 (4)	0.14	6.5 (4.6)	0.47
No	7.5 (4)		5.7 (4.1)
Heart disease
Yes	9 (4.6)	0.47	7.6 (4.8)	0.15
No	8.1 (3.9)		5.7 (4.1)
HTA
Yes	9 (4.1)	0.03	6.5 (4.6)	0.24
No	6.5 (3.6)		5.1 (3.4)
Obesity
Yes	7.5 (4)	0.43	6.9 (5.3)	0.49
No	8.5 (4)		5.9 (4.1)
Dysthyroidism
Yes	8.2 (3.7)	0.94	5.1 (2.8)	0.47
No	8.3 (4)		6.3 (4.5)
Complication type
Macroangiopathy
Yes	8.9 (3.8)	0.33	6.9 (4.5)	0.27
No	7.9 (4.3)		5.6 (4.2)
Nephropathy
Yes	11.3 (3.2)	0.024	8.1 (4.7)	0.18
No	7.8 (4)		5.8 (4.3)
Retinopathy
Yes	10.3 (4.1)	0.004	7.9 (4.6)	0.017
No	7.2 (3.7)		5.2 (3.9)
Peripheral neuropathy
Yes	9.4 (3.9)	0.10	8.1 (5.4)	0.005
No	7.6 (4.1)		4.9 (3)
Erectile dysfunction
Yes	7.3 (3.5)	0.67	7.3 (2.3)	0.64
No	8.3 (4.1)		6.1 (4.4)

AAS: anxiety average score; DAS: depression average score; (SD): standard deviation.